The Blood and Marrow Transplantation Program at Nicklaus Children's Hospital is South Florida’s first and most experienced care provider for children requiring blood or bone marrow transplantation. The program is one of only two pediatric blood and marrow transplant centers in South Florida and performs more than 30 blood and marrow transplants per year.
Established in 1991, the program was originally accredited in 2003 by the Foundation for the Accreditation of Cellular Therapies (FACT) for all aspects of blood or marrow transplantation (cellular therapy). The program continues to meet the rigorous FACT standards, having achieved its most recent re-accreditation in 2020. FACT accreditation is given to organizations that exceed standards in patient care and laboratory practices.
See our BMT survival rates
We treat patients with malignant and nonmalignant disorders, and use both Autologous and Allogeneic donors. It includes peripheral blood, bone marrow and cord blood (single or double), from HLA-matched family members, haplo-identical family members as well as unrelated donors.
Cutting Edge Therapy
The Helen & Jacob Shaham Cancer and Blood Disorders Institute at Nicklaus Children's Hospital is one of few in the state to offer the latest immune cell treatment for children and adolescents with certain types of leukemia.
The treatment, known as chimeric antigen receptor T-cell (CAR T) therapy uses a patient's own immune system cells to treat acute lymphoblastic leukemia (ALL) among other types of cancer. The Shaham Cancer & Blood Disorders Institute is an approved treatment facility to deliver the FDA- approved CAR T-Cell therapy to children and adolescents with certain types of pediatric cancers.
Multidisciplinary Pediatric Care
Our Pediatric BMT program is comprised of a multidisciplinary team of clinicians that come together to provide consultation, evaluation and follow up care to each individual patient’s needs.
Program Highlights
- Board-certified pediatricians and pediatric oncologists
- Nurse navigators
- Pediatric radiation oncology
- On-site stem cell harvesting for transplantation
- A Children's Oncology Group (COG) Member with access to the latest clinical trials
- National Marrow Donor Program (NMDP) Transplant Center
- Member of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC)
- Access to all unrelated donor registries for stem cell products
- Child Life Specialists
- Music Therapy
- Blood and Marrow Transplant-trained nursing staff
- Psychologists specialized in oncology and hematologic care, including sickle cell disease
- Bone Marrow Transplant failure program and follow up care
- Pediatric Advanced Care Team
Treatments and Procedures
Malignant conditions treated with Blood and Marrow Transplant
Non-malignant conditions treated with Blood and Marrow Transplant
Excellent Outcomes Close to Home
The Blood and Marrow Transplant Program maintains outcomes that are the best in the region as reported by the National Marrow Donor Program (NMDP). The program’s experience and dedication to quality and in-depth staff training continues to drive outcomes that well exceed predicted outcomes.
The Blood and Marrow Transplant (BMT) Program at Nicklaus Children’s has surpassed expected outcomes for patients receiving allogeneic (donor tissue) transplants, attaining an overall 93 percent survival rate for the years 2019 to 2021. This distinction is outlined in the Transplant Center-Specific Survival Report published recently by the Center for International Blood and Marrow Transplant Research (CIBMTR). To learn more about the Nicklaus Children’s BMT Program’s CIBMTR survival rates, click here.
The BMT Program at Nicklaus Children’s, one of only two pediatric blood and marrow transplant centers in South Florida, performs more than 30 blood and marrow transplants per year. Established in 1991, the program continues to meet the stringent FACT accreditation standards, having achieved its most recent reaccreditation in 2020.
Access to the Latest Research Protocols and Data
The Blood and Marrow Transplant Program is a Children’s Oncology Group (COG) accredited center for transplants and is a member of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and the International Blood and Marrow Transplant Registry (IBMTR). Membership in these organizations brings access to the very latest research protocols and national and international research data.